| 标题 |
 Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet Oncology 作者：Nicholas C. Turner; Erica L. Mayer; Yeon Hee Park; Wolfgang Janni; Cynthia Ma; et al 出版日期：2026-07-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
woshi123
v0id
yzy
cdercder
22336
Kao
aajhajkahna
xing_xing
云城
科研狗
整齐的慕卉
乐空思
lixinglei
yjh123
GingerF
aaaa
丰富语蕊
XLL小绿绿
OK
皖公网安备34019202002308
